Amwell (AMWL, $6.42) is preparing to unveil its first quarter 2026 operating results on May 5, marking a critical checkpoint in the Boston-based telehealth platform's journey toward operational cash flow breakeven. Analysts anticipate revenue of approximately $51.5 million for the quarter, with…